ALEXANDRIA, Va., Aug. 20 -- United States Patent no. 12,391,747, issued on Aug. 19, was assigned to Nordic Bioscience A/S (Herlev, Denmark).
"Type XXIII collagen assay" was invented by Tina Manon-Jensen (Brondby, Denmark), Shu Sun (Farum, Denmark), Joachim Hog Mortensen (Hundige Strand, Denmark) and Morten Karsdal (Kobenhavn O, Denmark).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides monoclonal antibodies that target collagen type XXIII, and to immunoassays and kits employing the antibodies for detecting and quantifying the epitope. The invention also provides a method for identifying and monitoring subjects with inflammatory bowel disease."
The patent was filed on Feb. 6, 2020,...